- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 407/04 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings directly linked by a ring-member-to-ring- member bond
Patent holdings for IPC class C07D 407/04
Total number of patents in this class: 721
10-year publication summary
|
36
|
46
|
45
|
37
|
42
|
29
|
38
|
43
|
32
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| LG Chem, Ltd. | 17745 |
21 |
| Merck Patent GmbH | 5729 |
21 |
| F. Hoffmann-La Roche AG | 7878 |
10 |
| Janssen Pharmaceutica N.V. | 3304 |
10 |
| Daewoong Pharmaceutical Co., Ltd. | 334 |
10 |
| Green Cross Corporation | 207 |
9 |
| SynDevRx, Inc. | 50 |
9 |
| Hoffmann-La Roche Inc. | 3620 |
8 |
| F.I.S. Fabbrica Italiana Sintetici S.p.A. | 131 |
8 |
| LT Materials Co., Ltd. | 420 |
8 |
| BASF SE | 21146 |
7 |
| Syngenta Participations AG | 1628 |
7 |
| SFC Co., Ltd. | 329 |
7 |
| Tokuyama Corporation | 1454 |
7 |
| Novartis AG | 10463 |
6 |
| Bristol-myers Squibb Company | 4795 |
6 |
| Centre National de La Recherche Scientifique | 10812 |
6 |
| Cumberland Pharmaceuticals Inc. | 94 |
6 |
| FMC Corporation | 813 |
6 |
| Vanderbilt University | 1953 |
6 |
| Other owners | 543 |